Evolent Health, Inc.·4

Feb 26, 4:38 PM ET

Weinberg Jonathan 4

4 · Evolent Health, Inc. · Filed Feb 26, 2024

Insider Transaction Report

Form 4
Period: 2024-02-22
Weinberg Jonathan
General Counsel
Transactions
  • Award

    Class A Common Stock

    2024-02-22+11,550161,519 total
  • Tax Payment

    Class A Common Stock

    2024-02-22$33.03/sh4,024$132,913157,495 total
Footnotes (3)
  • [F1]Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F3]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units.

Documents

1 file
  • 4
    wk-form4_1708983497.xmlPrimary

    FORM 4